Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification & Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid epitope tag with established use in antibody-mediated protein purification and detection workflows (product page). Its high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) enables flexible integration into experimental buffers. The HA tag ensures compatibility with a wide spectrum of validated anti-HA antibodies for both immunoprecipitation and competitive elution (Wei et al., 2021). Purity is confirmed by HPLC and mass spectrometry to be >98%. The tag's competitive binding facilitates specific elution of HA fusion proteins, minimizing background and enhancing reproducibility in protein-protein interaction studies (Precision Tag for Detection).

Biological Rationale

The HA tag peptide was originally derived from the influenza virus hemagglutinin protein, specifically from the amino acid sequence YPYDVPDYA. This region is recognized as a strong epitope for monoclonal antibody detection (Wei et al., 2021). The tag is not present in mammalian proteomes, reducing off-target interactions. As a result, the HA tag has become a standard for labeling recombinant proteins in eukaryotic, prokaryotic, and cell-free expression systems (Next-Generation Tag Overview).

By fusing the HA tag to a protein of interest, researchers can leverage anti-HA antibodies for highly specific immunoprecipitation, Western blotting, or immunofluorescence. The tag allows for direct detection or affinity-based purification without altering protein folding or function, provided it is fused at a permissive terminus. This approach accelerates studies of protein-protein interactions, post-translational modifications, and subcellular localization. Recent advances underscore its value in cancer and exosome research, where tagged proteins enable mechanistic dissection of trafficking and signaling events (Wei et al., 2021).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide functions as an epitope tag by providing a unique, antibody-recognizable sequence on recombinant proteins (A6004 product page). When incorporated into a fusion protein, the HA tag is targeted by anti-HA antibodies, enabling selective binding and capture.

During immunoprecipitation or affinity purification, the fusion protein is immobilized on anti-HA antibody-conjugated beads or resins. To elute the bound HA-tagged protein, an excess of free synthetic HA peptide (A6004) is added. This peptide competes for the antibody’s binding site, displacing the fusion protein in a highly specific and reversible manner (Precision Tag for Detection). The process preserves protein conformation and interactions, making it suitable for sensitive downstream analyses such as mass spectrometry or functional assays.

Evidence & Benchmarks

• HA peptide (YPYDVPDYA) consistently enables antibody-mediated immunoprecipitation and elution of HA-tagged proteins in cell lysates from human, mouse, and yeast systems (Wei et al., 2021).
• Purity of the A6004 peptide exceeds 98% (HPLC and MS analysis), minimizing background in competitive elution workflows (A6004 product datasheet).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water (room temperature, pH 7.0), supporting high-concentration applications (A6004 product datasheet).
• Competitive elution with synthetic HA peptide preserves protein complexes and post-translational modifications compared to harsh elution buffers (Mechanistic Precision).
• HA tag fusion does not interfere with protein folding or function when positioned at the N- or C-terminus in most recombinant constructs (Next-Generation Tag Overview).

Applications, Limits & Misconceptions

The HA tag peptide is a gold-standard tool for:

• Immunoprecipitation and co-immunoprecipitation (co-IP) of recombinant proteins using anti-HA antibodies or magnetic beads.
• Competitive elution of HA-tagged proteins for downstream functional or structural studies.
• Western blot detection and immunofluorescence imaging of HA-tagged proteins in diverse expression systems.
• Protein-protein interaction and post-translational modification studies in cell biology and translational research (Mechanistic Utility in Translational Research).

However, several boundaries and misconceptions should be clarified:

Common Pitfalls or Misconceptions

• The HA peptide does not facilitate cell entry or cross membranes; it functions solely as a molecular tag for antibody recognition.
• Not all anti-HA antibodies have equal affinity; experimental validation is necessary for each lot or vendor.
• Excessive use of HA peptide in elution can interfere with downstream mass spectrometry unless adequately removed.
• HA tag may disrupt protein function if inserted in critical structural or active domains.
• The presence of endogenous HA-like sequences in rare non-human organisms can lead to background but is negligible in standard mammalian systems.

This article extends previous coverage (Next-Generation Tag Overview) by providing detailed evidence benchmarks and clarifying practical limitations.

Workflow Integration & Parameters

The A6004 Influenza Hemagglutinin (HA) Peptide is supplied at >98% purity, lyophilized. For use, dissolve in DMSO, ethanol, or water to the desired concentration (e.g., 1–10 mg/mL). Store lyophilized peptide desiccated at -20°C to preserve stability. Avoid long-term storage of dilute peptide solutions; prepare fresh aliquots before use (product page).

Immunoprecipitation protocols typically employ 1–2 mM peptide (final concentration) for competitive elution. Buffer selection should be compatible with both protein of interest and downstream assays. Removal of eluted peptide can be achieved by dialysis or ultrafiltration prior to sensitive applications such as mass spectrometry.

For further guidance on optimizing competitive elution in complex workflows, see our in-depth comparison of HA peptide versus FLAG and Myc tags (Precision Tag for Detection), which this article updates by benchmarking A6004’s solubility and lot-to-lot consistency.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a cornerstone of modern protein biochemistry, enabling precise, reproducible protein detection and purification. Its unique sequence, high purity, and solution versatility assure consistent performance across a broad spectrum of experimental platforms. As antibody technologies and proteomic workflows evolve, the HA tag’s compatibility and specificity continue to drive its adoption in advanced translational and mechanistic research (Mechanistic Precision). Future developments may focus on multiplexed tagging strategies and integration with next-generation analytical tools, building on the robust foundation established by the HA tag system.